November 15, 2001Walgreen Co Recalls Lantus Insulin
Glargine (rDNA origin) Injection
Deerfield, IL (SafetyAlerts)
- The Food and Drug Administration (FDA) said that Walgreen Co. is recalling
Lantus Insulin Glargine (rDNA origin) Injection; 100 units/mL.
This is the first public notice of
recall issued by the FDA.
Lantus Insulin Glargine (rDNA origin) Injection; 100 units/mL (U-100)in 10
mL vials, 10 vials per pack; NDC #0088-2220-33,
All lots of Lantus U-100 Insulin distributed to Walgreens pharmacies between
5/2/01 and 9/7/01.
Walgreen Co., Deerfield, IL, by e-mail on 9/7/01.
Aventis Pharma AG Frankfurt am Main, Germany. Firm initiated recall is
Temperature Abuse-product shipped unrefrigerated by recalling firm.
VOLUME OF PRODUCT IN COMMERCE